enter
cell
use
spike
protein
also
main
target
neutral
antibodi
therefor
assay
measur
antibodi
sera
affect
spikemedi
viral
infect
import
studi
immun
viru
one
way
simplifi
assay
pseudotyp
viral
particl
spike
pseudotyp
describ
singlecycl
lentivir
retrovir
vsv
particl
reagent
protocol
wide
avail
detail
effect
pseudotyp
lentivir
particl
spike
infect
cell
engin
express
receptor
also
make
key
experiment
reagent
avail
bei
resourc
repositori
atcc
nih
furthermor
demonstr
pseudotyp
lentivir
particl
use
measur
neutral
activ
human
sera
plasma
conveni
luciferasebas
assay
therebi
provid
valuabl
complement
elisabas
method
measur
antibodi
bind
rather
neutral
wellcharacter
highthroughput
method
elisa
assay
measur
total
antibodi
bind
key
constitu
protein
quantifi
neutral
antibodi
activ
difficult
biolog
relev
method
directli
measur
antibodi
sera
inhibit
infect
cell
replicationcompet
liveviru
assay
perform
quantifi
neutral
activ
sera
infect
patient
character
potenc
individu
antibodi
howev
throughput
access
liveviru
neutral
assay
limit
fact
viru
agent
must
work
special
facil
altern
approach
allevi
biosafeti
limit
leverag
fact
known
neutral
antibodi
coronavirus
lack
protein
target
viru
spike
protein
spike
protrud
promin
surfac
virion
necessari
suffici
enabl
viru
bind
enter
cell
spike
sever
coronavirus
pseudotyp
onto
safer
nonrepl
viral
particl
place
endogen
entri
protein
therebi
make
entri
particl
cell
depend
spike
pseudotyp
recent
report
use
hivbas
lentivir
particl
mlvbase
retrovir
particl
vsv
data
report
date
result
pseudoviru
neutral
assay
correl
well
measur
made
use
live
howev
detail
protocol
reagent
perform
assay
yet
wide
avail
scientif
commun
fill
gap
provid
detail
descript
pseudotyp
lentivir
particl
spike
explain
pseudotyp
particl
use
conveni
measur
spikemedi
cell
entri
via
fluoresc
luciferas
report
quantifi
neutral
activ
human
plasma
final
describ
necessari
experiment
reagent
make
avail
bei
resourc
reagent
repositori
http
wwwbeiresourcesorg
basic
strategi
pseudotyp
lentivir
particl
shown
figur
involv
transfect
cell
lentivir
backbon
plasmid
encod
fluoresc
luminesc
report
protein
plasmid
express
spike
plasmid
express
minim
set
lentivir
protein
necessari
assembl
viral
particl
transfect
cell
produc
spikepseudotyp
lentivir
particl
use
infect
permiss
cell
express
receptor
protein
use
hivbas
lentivir
system
produc
viral
particl
pseudotyp
spike
shown
figur
system
requir
cotransfect
cell
lentivir
backbon
encod
report
protein
plasmid
expess
spike
plasmid
encod
hiv
protein
necessari
virion
format
tat
gagpol
rev
use
two
differ
lentivir
backbon
one
use
cmv
promot
drive
express
zsgreen
anoth
use
cmv
promot
drive
exprssion
luciferas
follow
intern
ribosom
entri
site
ire
zsgreen
hereaft
refer
zsgreen
luciferaseireszsgreen
backbon
transfect
cell
produc
lentivir
particl
spike
surfac
viral
particl
infect
cell
express
receptor
b
use
three
variant
spike
codonoptim
spike
strain
variant
contain
mutat
cytoplasm
tail
ctermin
five
amino
acid
alayt
variant
cytoplasm
tail
spike
replac
influenza
hemagglutinin
ha
c
spike
express
surfac
cell
transfect
plasmid
express
three
spike
construct
measur
use
flow
cytometri
hour
posttransfect
spike
express
measur
stain
inhous
produc
antibodi
concentr
follow
stain
antihuman
fc
antibodi
conjug
apc
jackson
lab
dilut
spike
protein
strain
use
ncbiannot
start
site
nucleotid
sequenc
codon
optim
express
human
cell
use
three
variant
spike
figur
first
variant
simpli
codonoptim
spike
second
variant
two
aminoacid
mutat
basic
residu
spike
cytoplasm
tail
chang
sequenc
five
ctermin
residu
alayt
variant
hereaft
refer
spikealayt
rational
spikealayt
origin
sarscov
two
analag
mutat
shown
improv
plasmamembran
express
spike
elimin
endoplasm
reticulum
retent
signal
third
variant
cytoplasm
tail
spike
replac
influenza
hemagglutinin
ha
variant
hereaft
refer
spikehatail
rational
spikehatail
origin
sarscov
delet
spike
cytoplasm
tail
replac
virus
shown
improv
pseudotyp
effici
valid
express
spike
surfac
cell
transfect
plasmid
express
three
variant
figur
sequenc
spike
lentivir
plasmid
file
plasmid
avail
bei
resourc
see
materi
method
bei
catalog
number
creat
target
cell
line
effici
infect
spikepseudotyp
lentivir
particl
transduc
cell
lentivir
vector
express
human
promot
lentivir
backbon
plasmid
sequenc
file
avail
bei
resourc
item
creat
clonal
cell
line
bulk
transduct
sort
singl
transduc
cell
flow
cytometri
reexpand
larg
popul
note
select
marker
cell
identifi
expand
clone
express
high
level
figur
express
appear
stabl
overtim
notic
decreas
twelv
passag
time
write
clone
hereaft
refer
avail
bei
resourc
item
viral
entri
protein
cell
incub
equal
volum
viru
cell
incub
th
volum
vsv
gpseudotyp
lentiviru
compar
spikepseudotyp
lentiviru
decreas
infect
cell
spikehatail
viru
compar
spikepseudotyp
lentivirus
consist
viru
somewhat
lower
titer
see
fig
valid
cell
suscept
infect
spikepseudotyp
lentivir
particl
incub
parent
equival
amount
viral
particl
carri
zsgreen
shown
figur
spikepseudotyp
virus
infect
cell
viru
pseudotyp
vsv
g
amphotrop
viral
entri
protein
depend
effici
infect
cell
line
figur
quantifi
titer
lentivir
particl
pseudotyp
spike
variant
produc
particl
spike
well
posit
control
use
vsv
g
neg
control
without
viral
entri
protein
first
produc
viral
particl
use
zsgreen
backbon
titer
flow
cytometri
determin
number
transduc
particl
per
ml
shown
figur
spike
variant
produc
titer
transduct
unit
per
ml
titer
two
order
magnitud
lower
achiev
vsv
g
consid
encouragingli
high
given
lentivir
particl
concentr
varieti
method
produc
viral
particl
use
luciferaseireszsgreen
backbon
found
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
could
achiev
titer
rel
luciferas
unit
rlu
per
ml
plate
infect
figur
titer
two
order
magnitud
lower
achiev
use
vsv
g
expect
magnitud
fluoresc
signal
zsgreen
lower
luciferaseireszsgreen
backbon
zsgreenonli
backbon
figur
sinc
zsgreen
former
construct
driven
ire
rather
primari
promot
seen
imag
zsgreen
backbon
give
stronger
fluoresc
signal
luciferaseireszsgreen
backbon
presum
protein
express
strongli
sole
cmvpromot
driven
transcript
second
transcript
driven
ire
next
use
luciferaseireszsgreen
virus
perform
neutral
assay
plate
rlu
per
well
plate
necessari
achiev
signal
background
luciferas
activ
virusonli
control
assay
requir
rel
modest
volum
viru
full
plate
neutral
assay
perform
neutral
assay
use
plasma
confirm
infect
patient
collect
day
postsymptom
onset
solubl
protein
fuse
igg
fc
domain
neutral
act
decoy
receptor
neg
control
expect
neutral
use
sera
collect
prior
emerg
late
bright
field
fluoresc
c
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
assay
first
made
serial
dilut
plasma
sera
solubl
plate
incub
dilut
minut
volum
pseudotyp
lentivir
particl
suffici
achiev
rlu
luciferas
signal
per
well
final
ad
mix
preseed
plate
cell
measur
luciferas
signal
hour
postinfect
see
materi
method
detail
protocol
plasma
confirm
patient
solubl
effect
neutral
viru
figur
b
plasma
inhibitori
concentr
three
spike
variant
rang
valu
report
sera
plasma
patient
similar
time
postinfect
solubl
spike
spikealaytpseudotyp
lentivir
particl
notabl
lower
spikehatail
pseudotyp
lentivir
particl
figur
measur
unmodifi
spike
higher
previous
report
solubl
suspect
differ
could
target
cell
express
high
level
make
resist
neutral
solubl
expect
neutral
pseudotyp
viru
either
pool
individu
human
sera
collect
date
prior
emerg
figur
result
equivoc
whether
cytoplasm
tail
modif
greatli
alter
neutral
sensit
plasma
neutral
three
spike
variant
spike
spikealayt
spikehatail
exhibit
similar
neutral
profil
figur
solubl
spikehatail
viru
notabl
neutral
sensit
two
spike
variant
figur
mechan
underli
distinct
neutral
sensit
observ
unclear
possibl
modifi
spike
cytoplasm
tail
may
alter
open
receptor
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
bind
domain
therefor
suggest
perform
assay
use
spike
without
cytoplasm
tail
modif
particularli
sinc
none
modif
test
greatli
improv
pseudotyp
lentivir
particl
titer
describ
detail
protocol
produc
spikepseudotyp
lentivir
particl
perform
neutral
assay
although
basic
pseudotyp
approach
describ
previous
provid
first
detail
protocol
make
reagent
avail
public
repositori
http
wwwbeiresourcesorg
hope
protocol
reagent
easili
enabl
other
assess
neutral
activ
antibodi
sera
reactiv
also
found
modifi
cytoplasm
tail
spike
greatli
improv
titer
spikepseudotyp
lentivir
particl
inde
one
cytoplasm
tail
modif
test
potenti
alter
neutral
sensit
pseudotyp
lentivir
particl
suggest
may
undesir
test
full
suit
cytoplasm
tail
modif
use
pseudotyp
spike
origin
sarscov
result
suggest
modif
cytoplasm
tail
spike
test
caution
overal
describ
easili
access
assay
studi
neutral
antibodi
respons
laboratori
assay
allow
human
sera
plasma
sampl
screen
conveni
format
help
facilit
test
larg
number
patient
sampl
better
understand
develop
immun
potenti
screen
donor
passiv
transfer
convalesc
plasma
sequenc
plasmid
use
studi
avail
genbank
format
file
also
http
plasmid
avail
bei
resourc
http
wwwbeiresourcesorg
follow
catalog
number
bei
catalog
number
lentivir
backbon
plasmid
express
human
gene
genbank
id
human
promot
intron
increas
express
lentivir
backbon
plasmid
use
cmv
promot
express
zsgreen
note
plasmid
ampicillin
resist
plasmid
use
studi
bei
resourc
catalog
hdmvsvg
plasmid
express
vsv
g
cmv
promot
use
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
creat
posit
control
lentiviru
pseudotyp
vsv
g
howev
numer
vsv
g
express
plasmid
avail
addgen
repositori
vsv
gpseudotyp
lentiviru
packag
human
gener
via
cotransfect
cell
atcc
plasmid
file
lentivir
helper
plasmid
hdmvsvg
result
lentiviru
use
infect
cell
presenc
ugml
polybren
transduc
cell
stain
antihuman
polyclon
goat
igg
r
system
primari
antibodi
ugml
donkey
antigoat
igg
conjug
alexa
fluor
abcam
secondari
antibodi
dilut
sort
base
antibodi
stain
singl
cell
clone
grown
suffici
screen
express
via
flow
cytometri
clone
high
express
expand
name
figur
verifi
express
via
flow
cytometri
cell
harvest
enzymefre
dissoci
buffer
thermofish
stain
antihuman
polyclon
goat
igg
primari
antibodi
ugml
donkey
antigoat
igg
alexa
fluor
secondari
antibodi
dilut
stain
step
cell
incub
antibodi
dark
c
min
cell
wash
time
bsa
pb
follow
stain
cell
grown
growth
media
dmem
heatinactiv
fb
mm
lglutamin
uml
penicillin
ugml
streptomycin
c
carbon
dioxid
note
select
marker
express
cell
avail
bei
resourc
catalog
number
pseudotyp
lentivirus
gener
transfect
depict
figur
use
follow
protocol
seed
cell
growth
media
see
subsect
media
composit
confluent
next
day
plate
cell
per
well
cell
per
ml
hour
seed
transfect
cell
plasmid
requir
lentivir
product
transfect
use
biot
bioland
scientif
follow
manufactur
instruct
use
follow
plasmid
mix
per
well
plate
plasmid
amount
adjust
larger
plate
um
filter
viru
store
c
immedi
use
frozen
c
titer
spikeand
vsv
gpseudotyp
lentivirus
found
unaffect
freezethaw
cycl
data
shown
titer
present
viru
frozen
c
prior
use
determin
viral
titer
use
either
flow
cytometri
virus
packag
zsgreen
backbon
luciferas
assay
virus
packag
luciferaseireszsgreen
backbon
detail
titer
protocol
describ
differ
two
readout
note
viru
well
provid
background
signal
viru
cell
well
repres
maximum
infect
without
serum
provid
metric
viru
infect
note
cell
refer
cell
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
follow
protocol
develop
streamlin
neutral
assay
spikepseudotyp
lentivirus
protocol
perform
either
human
sera
plasma
monoclon
antibodi
note
safeti
sera
plasma
heatinactiv
biosafeti
cabinet
prior
use
describ
subsect
seed
polyllysineco
plate
cell
bei
per
well
ul
dmem
cell
per
ml
plan
infect
plate
hour
postseed
hour
prior
infect
cell
begin
prepar
serum
andor
dilut
separ
setup
plate
serial
dilut
serum
sampl
leav
ul
dilut
serum
well
data
figur
start
initi
serum
dilut
serial
dilut
mean
replic
assay
requir
ul
sera
fig
start
concentr
ugml
serial
dilut
b
add
ul
well
correspond
viru
viru
plu
cell
control
well
add
ul
media
cell
control
well
see
figur
exampl
plate
layout
dilut
viru
rlu
per
ml
add
ul
dilut
viru
well
contain
serum
dilut
viru
viru
plu
cell
control
well
incub
viru
serum
c
hr
care
add
ul
well
setup
plate
contain
sera
viru
dilut
correspond
well
plate
cell
add
polybren
sigma
aldrich
describ
subsect
final
concentr
ugml
well
incub
c
hour
read
luminesc
fluoresc
describ
subsect
plot
data
curv
shown
figur
fit
plot
data
use
neutcurv
python
packag
http
jbloomlabgithubioneutcurv
human
plasma
sampl
use
figur
collect
day
postsymptom
onset
patient
confirm
infect
prior
use
plasma
heatinactiv
biosafeti
cabinet
c
one
hour
durat
heat
treatment
shown
suffici
inactiv
also
report
present
high
titer
blood
neg
control
serum
pool
came
gemini
bioscienc
serum
pool
collect
lot
agematch
neg
control
serum
come
serum
residu
collect
bloodwork
northwest
collect
store
c
solubl
human
protein
fuse
fc
region
human
igg
produc
describ
fusion
protein
use
figur
supplementari
materi
file
zip
file
contain
plasmid
map
genbank
format
